BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15364436)

  • 1. Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines.
    Brandileone MC; Andrade AL; Teles EM; Zanella RC; Yara TI; Di Fabio JL; Hollingshead SK
    Vaccine; 2004 Sep; 22(29-30):3890-6. PubMed ID: 15364436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil.
    Pimenta FC; Ribeiro-Dias F; Brandileone MC; Miyaji EN; Leite LC; Sgambatti de Andrade AL
    J Clin Microbiol; 2006 Aug; 44(8):2838-43. PubMed ID: 16891500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.
    Vela Coral MC; Fonseca N; Castañeda E; Di Fabio JL; Hollingshead SK; Briles DE
    Emerg Infect Dis; 2001; 7(5):832-6. PubMed ID: 11747695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children.
    Heeg C; Franken C; van der Linden M; Al-Lahham A; Reinert RR
    Vaccine; 2007 Jan; 25(6):1030-5. PubMed ID: 17084949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.
    Poulakou G; Katsarolis I; Matthaiopoulou I; Tsiodras S; Kanavaki S; Hatzaki D; Roilides E; Sofianou D; Kavaliotis I; Kansouzidou A; Kafetzis DA; Paraskakis I; Foustoukou M; Daikos GL; Syriopoulou V; Pangalis A; Leveidiotou S; Giamarellou H;
    Int J Antimicrob Agents; 2007 Jul; 30(1):87-92. PubMed ID: 17540542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of PspA families and pilus islets among Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil.
    Knupp-Pereira PA; Marques NTC; Teixeira LM; Póvoa HCC; Neves FPG
    Braz J Microbiol; 2020 Jun; 51(2):419-425. PubMed ID: 31802411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
    Laval CB; de Andrade AL; Pimenta FC; de Andrade JG; de Oliveira RM; Silva SA; de Lima EC; Fabio JL; Casagrande ST; Brandileone MC
    Clin Microbiol Infect; 2006 Jan; 12(1):50-5. PubMed ID: 16460546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
    J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Streptococcus pneumoniae isolated from children with otitis media.
    Onwubiko C; Shires C; Quin LR; Swiatlo E; McDaniel LS
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):119-25. PubMed ID: 17456178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan.
    Hotomi M; Billal DS; Kamide Y; Kanesada K; Uno Y; Kudo F; Ito M; Kakehata S; Sugita R; Ogami M; Yamanaka N;
    J Clin Microbiol; 2008 Nov; 46(11):3808-10. PubMed ID: 18832131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC; Bosarge JR; Quin LR; McDaniel LS
    Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany.
    Reinert RR; van der Linden M; Seegmüller I; Al-Lahham A; Siedler A; Weissmann B; Toschke AM; von Kries R
    Clin Microbiol Infect; 2007 Apr; 13(4):363-8. PubMed ID: 17359319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversity of pneumococcal surface protein A (PspA) in paediatric isolates of non-conjugate vaccine serotypes in Japan.
    Kawaguchiya M; Urushibara N; Aung MS; Morimoto S; Ito M; Kudo K; Kobayashi N
    J Med Microbiol; 2018 Aug; 67(8):1130-1138. PubMed ID: 29927374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines.
    Greenberg D
    Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
    Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.